For a printable version of the programme, click here.

THURSDAY, November 7, 2019 – Pre Congress Courses
13:30-18:30 Fertility Preservation Hands-on Workshop
Chair: Dror Meirow, Israel
14:00-18:30 Preimplantation genetic testing (PGT): Latest insights
Chair: Avner Hershlag, USA
13:30-13:55 Cryopreservation of ovarian tissue and its role among other FP procedures
Dror Meirow, Israel
14:00-14:10 Welcome and opening remarks
Avner Hershlag, USA
13:55-14:20 How to handle ovarian tissue preparation for cryopreservation and immature oocyte collection during procedure
Daniela Nogueira, France
14:10-14:40 Genetics for the non-geneticist
Yuval Yaron, Israel
14:20-14:45 Transplantation of ovarian tissue
Dror Meirow, Israel
14:40-15:10 PGT-A shifting technology
David Chrimes, USA
14:45-15:10 Safety- Searching for cancer cells in ovarian tissue
Hila Raanani, Israel
15:10-15:40 Evidence-based approach to PGT-A (to include Mosaicism)
Susan Maxwell, USA
15:10-15:30 Coffee Break 15:40-16:00 Coffee Break
15:30-18:30 Hands-On 16:00-16:30 PGT-M for single gene mutations
Avner Hershlag, USA
Clinical dilemmas
Patient cases for Fertility Preservation
Hila Raanani, Dror Meirow
Laboratory, surgical
Daniela Nogueira, Itay Spector, Dror Meirow
16:30-17:00 Ethical and Legal Issues with PGT
Joyce Harper, UK
17:00-17:30 Where is PGT going next? : a look to the future
Alan Handyside, UK
17:30-18:30 Q&A and Panel Discussion
18:30 Welcome Reception
FRIDAY, November 8, 2019
08:30-10:00 Session 1: Female gametogenesis
Chairs: Milton Leong,
Hong Kong; Zeev Shoham, Israel; David Albertini, USA
08:30-09:00 Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease
Choudhary Meenakshi, UK
09:00-09:30 Manipulation of follicle activation and its effect on ovarian reserve – using AMH
Zeev ShohamIsrael & Sherman SilberUSA
09:30-10:00 Developing Technology Platforms for female gametogenesis
Evelyn Telfer, UK
10:00-10:30 Coffee, poster viewing and visit the exhibition
10:30-13:30 Session 2: Fertility preservation
Chairs: Ana Cobo,
Spain; Dror Meirow, Israel
10:30-11:00 New insight to oocyte freezing
Ana Cobo, Spain
11:00-11:30 Microfluidics and ART- the big potential of tiny volumes
Helen Picton, UK
11:30-12:00 Freeze dry and automated cryopreservation technology
Amir Arav, Israel
12:00-12:30 Stem cells in the treatment of human infertility
Sherman Silber, USA
12:30-13:00 Freezing of ovarian tissue beyond fertility preservation in cancer patients
Claus Yding Andersen, Denmark
13:00-13:30 Lunch, poster viewing and visit the exhibition
13:30-14:00 The Incredible Journey of Robert Edwards: Scientist and Sphinx
Roger Gosden, USA
14:00-16:00 Session 3: Implantation-Uterine Receptivity: Clinical and Experimental Findings
Chairs: Roy Homburg,
UK;Helen Picton, UK
14:00-14:30 Signal of the endometrium ready for implantation: genetic clinical diagnosis
Xavier Santamaría, Spain
14:30-15:00 Chronic endometritis, endometriosis and the Microbiota’s role in implantation
Dominique de Ziegler, France
15:00-15:30 Fluorescence Lifetime Imaging Microscopy: egg and embryos under observation
Denny Sakkas, USA
15:30-16:00 Clinical and molecular view of the endometrium and the process of implantation: A better understanding
Rong Li, China
16:00-16:30 Coffee Break & Poster Viewing
16:30-18:00 Session 4: The IVF babies – Review the outcome
Chairs: Evelyn Telfer,
UK; Ariel Weissman, Israel
16:30-17:00 Should we be alarmed that designer babies walk among us?
Gerald Schatten, USA
17:00-17:30 The health of children conceived by ART: The chicken or the egg?
Anja Pinborg, Denmark
17:30-18:00 The targeted treatment for patients with low ovarian reserve
Raphael Ron-El, Israel
SATURDAY, November 9, 2019
08:30-10:30 Session 5: The rise and fall of the ovary: from its organogenesis to disorders
Chairs: Pasqualino Loi,
Italy; David Albertini, USA
08:30-09:00 New Insights into the Establishment of the Ovarian Reserve
Humphrey Yao, USA
09:00-09:30 Engineering a bioprosthetic ovary
Monica Laronda, USA
09:30-10:00 The key for future fertility treatment: Direct production of gametes through Haploydization of totipotent somatic nuclei
Pasqualino Loi, Italy
10:00-10:30 Estrogen, receptors actions, fertility and ovarian function
Kenneth Korach, USA
10:30-11:00 Coffee, poster viewing and visit the exhibition
11:00-13:00 Session 6: Between Cutting Edge and Grey Zone Controversies
Chairs: Seang Lin Tan,
Canada; Samir Hamamah, France
11:00-11:30 Best results for PCOS in IVF: What is the evidence?
The importance of AMH levels. Agonist or antagonist? FSH or FSH + LH? Should metformin be given on a routine basis?
Agonist or hCG trigger? Should we use the ‘freeze-all” protocol? When to use IVM?
Roy Homburg, UK
11:30-12:00 Do an endometrioma per se affect ovarian reserve?
Does it affect ovarian reserve?, IVF results? Does cystectomy improve IVF results? Surgery or drug therapy should come first? What about fertility preservation?
Johnny Younis, IL
12:00-12:30 Fertility and intramural fibroids: what is the evidence?
Ariel Weissman, IL
12:30-13:00 hCG vs GnRH-agonist for final maturation of the oocyte?
Rate of OHSS with each drug, Can GnRH-agonist replace hCG in regard to oocyte maturation ? Is pregnancy rate different with each stimulation ? Is time of oocyte collection the same in regards to each drug?
Robert Fischer, Germany
13:00-13:45 Lunch, poster viewing and visit the exhibition
13:45-15:45 Session 7: Ovarian aging and AMH
Chair: Robert Fischer,
13:45-14:15 Ovarian aging, evolutionary perspective
David Albertini, USA
14:15-14:45 AMH for whom?
Antonio La Marca, Italy
14:45-15:15 AFC/AMH and ovarian reserve: are they competitors or complementary?
Samir Hamamah, France
15:15-15:45 Racial difference in ART success?
Milton Leong, Hong Kong
15:45-16:00 Coffee, poster viewing and visit the exhibition
16:00-17:30 Joint session with the CoGEN congress
Session 8: Debate: Only evidence based treatments should be offered in ART
Moderator: Darren Griffin, 
16:00-16:45 FOR: Joyce Harper, UK
16:45-17:30 AGAINST: Charles Kingsland, UK
17:30-17:40 Closing remarks